We are live on ! Find out more
ENZ

Enzo Biochem, Inc.
ENZ

Delisted

ENZ was delisted on the 17th of April, 2025.

Back to rankings

41 hedge funds and large institutions have $4.96M invested in Enzo Biochem, Inc. in 2025 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 9 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 9 | Existing positions reduced: 9

9% less funds holding

Funds holding: 45 → 41 (-4)

49% less capital invested

Capital invested by funds: $9.8M → $4.96M (-$4.84M)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
41
Holders Change
-4
Holders Change %
-8.89%
% of All Funds
0.55%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.01%
New
3
Increased
9
Reduced
9
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$91.1K
2
WIM
Wittenberg Investment Management
Massachusetts
+$47.8K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$35.3K
4
Squarepoint
Squarepoint
New York
+$33.8K
5
UBS Group
UBS Group
Switzerland
+$25.1K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$158K
2
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
-$87K
3
BCM
Bridgeway Capital Management
Texas
-$55.3K
4
EGM
Engineers Gate Manager
New York
-$37.3K
5
Millennium Management
Millennium Management
New York
-$23.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
TPA
26
Trivium Point Advisory
Connecticut
$7.21K – – –
BBA
27
Baader Bank Aktiengesellschaft
Germany
$6.63K +$12.5K +22,678 New
Raymond James Financial
28
Raymond James Financial
Florida
$6.3K – – –
SDAM
29
Shulman DeMeo Asset Management
New York
$5.73K – – –
VF
30
Virtu Financial
New York
$4K -$20.1K -36,421 -75%
TRCT
31
Tower Research Capital (TRC)
New York
$3.11K -$1.59K -2,887 -22%
Bank of America
32
Bank of America
North Carolina
$1.47K +$965 +1,747 +79%
MWA
33
Medallion Wealth Advisors
Connecticut
$1.04K – – –
JP Morgan Chase
34
JP Morgan Chase
New York
$708 -$4 -8 -0.4%
FVIM
35
Fort Vancouver Investment Management
Washington
$592 +$883 +1,599 New
Wells Fargo
36
Wells Fargo
California
$294 – – –
PNC Financial Services Group
37
PNC Financial Services Group
Pennsylvania
$259 – – –
Fidelity Investments
38
Fidelity Investments
Massachusetts
$159 -$70 -126 -23%
SIS
39
Sound Income Strategies
Florida
$4 – – –
EGM
40
Engineers Gate Manager
New York
– -$37.3K -52,281 Closed
Millennium Management
41
Millennium Management
New York
– -$23.1K -32,386 Closed
HF
42
HRT Financial
New York
– -$11K -16,537 Closed
Manulife (Manufacturers Life Insurance)
43
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$10.7K -14,955 Closed
TA
44
TLS Advisors
Florida
– -$10K -13,616 Closed
BL
45
BFSG LLC
California
– -$1.43K -2,000 Closed
Simplex Trading
46
Simplex Trading
Illinois
– -$150 -272 -99%
1
2

ENZ Hedge Fund Activity: Q1 2025 in Review

41 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Enzo Biochem, Inc. (ENZ) for Q1 2025, worth a combined $4.96M — down 49% from $9.8M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ENZ and 3 opened new positions — a net loss of 3 holders — while 9 trimmed existing stakes and 9 added.

The largest buyer was Citadel Advisors, adding an estimated $91.1K. The largest seller was Renaissance Technologies, cutting an estimated $158K.

  • 41 institutional investors held Enzo Biochem, Inc. (ENZ) as of Q1 2025, down from 45 in Q4 2024.
  • Funds reported $4.96M of Enzo Biochem, Inc. stock for Q1 2025, down 49% quarter-over-quarter.
  • 3 funds opened new Enzo Biochem, Inc. positions in Q1 2025 and 6 closed out, a net change of -3 holders.
  • The largest Enzo Biochem, Inc. buyer in Q1 2025 was Citadel Advisors, an estimated $91.1K added.
  • The largest Enzo Biochem, Inc. seller in Q1 2025 was Renaissance Technologies, an estimated $158K sold.

Based on aggregated 13F filings for Q1 2025.